Ignite Creation Date:
2024-05-06 @ 11:25 AM
Last Modification Date:
2024-10-26 @ 12:45 PM
Study NCT ID:
NCT03513952
Status:
COMPLETED
Last Update Posted:
2024-07-03
First Post:
2018-05-01
Brief Title:
Atezolizumab and CYT107 in Treating Participants With Locally Advanced Inoperable or Metastatic Urothelial Carcinoma
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Unresectable Ureter Urothelial Carcinoma |
| Advanced Bladder Urothelial Carcinoma |
| Advanced Ureter Urothelial Carcinoma |
| Metastatic Bladder Urothelial Carcinoma |
| Metastatic Renal Pelvis Urothelial Carcinoma |
| Metastatic Ureter Urothelial Carcinoma |
| Metastatic Urethral Urothelial Carcinoma |
| Metastatic Urothelial Carcinoma |
| Recurrent Bladder Urothelial Carcinoma |
| Recurrent Renal Pelvis Urothelial Carcinoma |
| Recurrent Ureter Urothelial Carcinoma |
| Recurrent Urethral Urothelial Carcinoma |
| Stage III Bladder Cancer AJCC v8 |
| Stage III Renal Pelvis Cancer AJCC v8 |
| Stage III Ureter Cancer AJCC v8 |
| Stage III Urethral Cancer AJCC v8 |
| Stage IV Bladder Cancer AJCC v8 |
| Stage IV Renal Pelvis Cancer AJCC v8 |
| Stage IV Ureter Cancer AJCC v8 |
| Stage IV Urethral Cancer AJCC v8 |
| Stage IVA Bladder Cancer AJCC v8 |
| Stage IVB Bladder Cancer AJCC v8 |
| Unresectable Bladder Urothelial Carcinoma |
| Unresectable Renal Pelvis Urothelial Carcinoma |
Keywords: